Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Colon Cancer
  •  Central Nervous System Tumors
  •  Paediatric Cancers
  •  Gynecological Cancers
  •  Cervical Cancer
  •  Melanoma/Skin Cancer
  •  Head and Neck Oncology
  •  Radiological Techniques and Scans

Abstract

Citation: Clin Oncol. 2022;7(1):1933.DOI: 10.25107/2474-1663.1933

Postoperative 5-Year Survival and Related Risk Factors of Colon Cancer Patients Undergoing Propofol vs. Sevoflurane
Anesthesia: A Retrospective Cohort Study

Jian Xu, Zhenglian Gao, Mark Coburn, Daqing Ma and Kun Wang

Department of Anesthesiology, Harbin Medical University Cancer Hospital, China
Department of Anesthesiology, Canzhou Central Hospital, China
Department of Anesthesiology, Panzhihua Central Hospital, China
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany
Department of Surgery and Cancer, Chelsea and Westminster Hospital, UK
Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, China

*Correspondance to: Kun Wang 

 PDF  Full Text Research Article | Open Access

Abstract:

Purpose: Anesthetic agents affect the biological behavior of tumor cells and long-term oncologic outcomes. We investigated the association of anesthetics and 5-year survival of colon cancer patients.
Methods: The data from patients underwent colon cancer surgery from July 01st, 2009 to July 31st, 2014 were analyzed. Patients were grouped according propofol or sevoflurane used during surgery. Five-year survivals were analyzed with Kaplan-Meier method, and Cox regression models were used to identify risk factors of death.
Results: Of 1,289 colon cancer patients, 913 patients with propofol anesthesia and 376 with sevoflurane anesthesia were eligible for analysis. After propensity score matching, 375 patients remained in each group, and 5-year overall survival was 79.7% (95% Confidence Interval [CI], 0.76-0.84) in the propofol group, and 78.1% (95% CI, 0.74-0.82) in the sevoflurane group, and 5-year
recurrence-free survival was 73.4% (95% CI, 0.69-0.78) and 70.4% (95% CI, 0.66-0.75), respectively. Type of anesthetic did not affect 5-year overall survival and recurrence-free survival with the logrank test (P=0.513, 0.293, respectively). Related risk factors were age, anesthesia duration, open surgery, CEA and CA199 values, vascular or nerve infiltration, TNM, and adjuvant therapy.
Conclusion: There were no benefits in 5-year survival in propofol anesthesia vs. sevoflurane anesthesia after colon cancer surgery.

Keywords:

Propofol; Sevoflurane; Colon cancer; Surgery; Survival; Risk factors

Cite the Article:

Xu J, Gao Z, Coburn M, Ma D, Wang K. Postoperative 5-Year Survival and Related Risk Factors of Colon Cancer Patients Undergoing Propofol vs. Sevoflurane Anesthesia: A Retrospective Cohort Study. Clin Oncol. 2022;7:1933..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Microcalcifications: A Study Based on the 5th Edition of BI-RADS
 Abstract  PDF  Full Text
Variations in Radiosensitivity of Breast Cancer and Normal Breast Cell Lines Using a 200 MeV Clinical Proton Beam
 Abstract  PDF  Full Text
View More...